RC-3095, a Gastrin-Releasing Peptide Receptor Antagonist, Synergizes With Gemcitabine to Inhibit the Growth of Human Pancreatic Cancer CFPAC-1 In Vitro and In Vivo.
- Resource Type
- Article
- Source
- Pancreas; Jan2014, Vol. 43 Issue 1, p15-21, 7p
- Subject
- Language
- ISSN
- 08853177